Non-clinical Safety Evaluation of Biotherapeutics – Challenges, Opportunities and new Insights-Reference-Cited by-同舟云学术

Non-clinical Safety Evaluation of Biotherapeutics – Challenges, Opportunities and new Insights

Published:2016-10 Issue: Volume:80 Page:S1-S14
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Blaich Guenter,Baumann Andreas,Kronenberg Sven,de Haan Lolke,Ulrich Peter,Richter Wolfgang F.,Tibbitts Jay,Chivers Simon,Tarcsa Edit^ORCID,Caldwell Robert,Crameri Flavio

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference52 articles.

1. Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?;Baumann;Drug Discov. Today,2014

2. The immunogenicity of antibody aggregates in a novel transgenic mouse model;Bessa;Pharm. Res.,2015

3. Non-clinical pharmacokinetic/pharmacodynamic and early clinical studies supporting development of a novel subcutaneous formulation for the monoclonal antibody rituximab;Bittner;Drug Res. Stuttg.,2014

4. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β;Bohrmann;J. Alzheimers Dis.,2012

5. Protein aggregates seem to play a key role among the Parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice;Braun;Pharm. Res.,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives;Biochemical Pharmacology;2024-07

2. Exploring Greater Flexibility for Chronic Toxicity Study Designs to Support Human Safety Assessment While Balancing 3Rs Considerations;International Journal of Toxicology;2024-05-31

3. Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker;Frontiers in Pharmacology;2023-12-06

4. Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach;Regulatory Toxicology and Pharmacology;2023-02

5. Evaluation of subchronic toxicity of the compound of diphenhydramine hydrochloride and caffeine after 28 days of repeated oral administration in Sprague-Dawley rats and beagle dogs;Drug and Chemical Toxicology;2022-11-16